N@N

Luke Sergott Initiated (TXG) at Buy and Held Target at $65 on, May 10th, 2023

Luke Sergott of Barclays, Initiated "10x Genomics, Inc." (TXG) at Buy and Held Target at $65 on, May 10th, 2023.

Luke has made no other calls on TXG in the last 4 months.

There are 6 other peers that have a rating on TXG. Out of the 6 peers that are also analyzing TXG, 1 agrees with Luke's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• John Sourbeer of "UBS" Initiated at Hold and Held Target at $50 on, Thursday, February 2nd, 2023

These are the ratings of the 5 analyists that currently disagree with Luke

---

• Dan Brennan of "TD Cowen" Maintained at Buy with Increased Target to $66 on, Thursday, May 4th, 2023
• Daniel Arias of "Stifel" Maintained at Strong Buy with Increased Target to $68 on, Thursday, May 4th, 2023
• Kyle Mikson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $65 on, Thursday, May 4th, 2023
• Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $65 on, Thursday, May 4th, 2023
• Tejas Savant of "Morgan Stanley" Maintained at Buy with Increased Target to $65 on, Thursday, February 16th, 2023

Contributing Sources

---